SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-24-010877
Filing Date
2024-04-03
Accepted
2024-04-03 16:17:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A zvra20240402_defa14a.htm DEFA14A 13555
2 yw2e_zeronoticepage1.jpg GRAPHIC 191159
3 yw2e_zeronoticepage2.jpg GRAPHIC 166288
  Complete submission text file 0001437749-24-010877.txt   507226
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36913 | Film No.: 24818968
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)